Fisher & Paykel Healthcare, a leading innovator in the medical device industry, is headquartered in New Zealand. Established in 1971, the company has made significant strides in the development of advanced respiratory and acute care products, primarily serving hospitals and homecare settings. With a strong presence in North America, Europe, and Asia-Pacific, Fisher & Paykel Healthcare has become synonymous with high-quality, patient-centric solutions. The company is renowned for its unique humidification systems and non-invasive ventilation technologies, which enhance patient comfort and outcomes. Over the years, Fisher & Paykel Healthcare has achieved notable milestones, including recognition for its commitment to research and development. As a market leader, it continues to set benchmarks in the healthcare sector, driven by a dedication to innovation and excellence.
How does Fisher And Paykel Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Fisher And Paykel Healthcare's score of 59 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Fisher & Paykel Healthcare reported total carbon emissions of approximately 316,855,000 kg CO2e. This figure includes 2,123,000 kg CO2e from Scope 1 emissions, 12,253,000 kg CO2e from Scope 2 emissions (market-based), and a significant 302,479,000 kg CO2e from Scope 3 emissions. In comparison, the previous year, 2023, the total emissions were about 341,705,000 kg CO2e, with Scope 1 at 2,287,000 kg CO2e, Scope 2 at 11,105,000 kg CO2e (market-based), and Scope 3 at 328,313,000 kg CO2e. Fisher & Paykel Healthcare has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 greenhouse gas emissions by 67% by FY2034, using FY2019 as the base year. Additionally, the company has committed that 87% of its suppliers, by spend, covering purchased goods and services and the use of sold products, will have science-based targets by FY2024. These targets align with the Science Based Targets initiative (SBTi) and are designed to contribute to limiting global warming to 1.5°C. Overall, Fisher & Paykel Healthcare's emissions data and climate commitments reflect a proactive approach to sustainability, with a clear focus on reducing their carbon footprint and engaging suppliers in climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 2,104,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 9,094,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 41,793,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Fisher And Paykel Healthcare has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


Common questions about Fisher And Paykel Healthcare's sustainability data and climate commitments